Showing results (291-300 of 398) with videos related to
Sort By:
Pageof 40
The New England Journal of Medicine|February 9, 1989
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarctionA G Turpie, J G Robinson, D J Doyle, et al.Research and Practice in Thrombosis and Haemostasis|April 19, 2021
Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA-LEA noninterventional studiesSylvia Haas, Lorenzo G Mantovani, Reinhold Kreutz, et al.Stroke|October 1, 1988
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline resultsM Gent, J A Blakely, J D Easton, et al.American Heart Journal|August 9, 2005
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patientsNiranjan Seshadri, Samuel Z Goldhaber, Uri Elkayam, et al.Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venographyF Piovella, C-J Wang, H Lu, et al.British Journal of Haematology|August 21, 2018
Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA studyFrederikus A Klok, Stefano Barco, Alexander G G Turpie, et al.Annals of Internal Medicine|December 29, 1998
Use of a clinical model for safe management of patients with suspected pulmonary embolismP S Wells, J S Ginsberg, D R Anderson, et al.European Journal of Internal Medicine|October 22, 2018
Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosisLorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, et al.BMJ (Clinical Research Ed.)|January 28, 2006
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialAlexander T Cohen, Bruce L Davidson, Alexander S Gallus, et al.Journal of Thrombosis and Haemostasis : JTH|June 19, 2013
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approachJ M Kittelson, A C Spyropoulos, J L Halperin, et al.Pageof 40